GeneDx Holdings (WGS) Total Liabilities (2020 - 2025)
Historic Total Liabilities for GeneDx Holdings (WGS) over the last 6 years, with Q3 2025 value amounting to $201.6 million.
- GeneDx Holdings' Total Liabilities fell 131.89% to $201.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $201.6 million, marking a year-over-year decrease of 131.89%. This contributed to the annual value of $174.1 million for FY2024, which is 870.61% down from last year.
- GeneDx Holdings' Total Liabilities amounted to $201.6 million in Q3 2025, which was down 131.89% from $186.7 million recorded in Q2 2025.
- Over the past 5 years, GeneDx Holdings' Total Liabilities peaked at $407.6 million during Q2 2021, and registered a low of $163.0 million during Q3 2023.
- Over the past 5 years, GeneDx Holdings' median Total Liabilities value was $195.1 million (recorded in 2024), while the average stood at $224.8 million.
- Per our database at Business Quant, GeneDx Holdings' Total Liabilities surged by 126633.1% in 2021 and then plummeted by 5371.69% in 2022.
- GeneDx Holdings' Total Liabilities (Quarter) stood at $166.0 million in 2021, then skyrocketed by 42.92% to $237.2 million in 2022, then fell by 19.6% to $190.7 million in 2023, then fell by 8.71% to $174.1 million in 2024, then increased by 15.8% to $201.6 million in 2025.
- Its Total Liabilities was $201.6 million in Q3 2025, compared to $186.7 million in Q2 2025 and $189.0 million in Q1 2025.